Selank Restores Cognitive Function After Early Brain Damage in Rats

The cerebral catecholamine system, a network of neurons crucial for regulating mood, attention, and cognitive function, can be severely damaged during early ontogeny (early development). Such damage, often caused by neurotoxins, leads to persistent cognitive impairments affecting learning, memory, and attention throughout life. This study specifically addresses the knowledge gap of whether the synthetic peptide Selank can effectively restore these disordered cognitive processes following early-life damage to the catecholamine system.

The study found that Selank treatment profoundly improved cognitive functions in the rats with early-life brain damage. Specifically, administration of Selank at 0.3 mg/kg led to a significant restoration of learning abilities, memory retention, and attention to various sensory stimuli. The cognitive performance of the Selank-treated rats was notably enhanced compared to untreated controls, demonstrating a robust therapeutic effect. These improvements were observed across multiple cognitive domains, suggesting a broad impact on brain function. The most important finding was that Selank effectively normalized cognitive processes that were severely impaired by chronic artificial inhibition of the cerebral catecholaminergic system during early development.